NCT03226093View on ClinicalTrials.gov

Safety Analysis of Implantation of Stromal Vascular Fraction

NACompletedINTERVENTIONAL
Enrollment

676

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

June 1, 2017

Conditions
Safety Issues
Interventions
PROCEDURE

Stromal Vascular Fraction

The fat was separated via centrifuge to isolate the SVF and the cells were delivered intraarticularly, intravenously, intrathecally, or intradiscally directly into the same patient

Sponsors

Lead Sponsor

Bioheart, Inc.
All Listed Sponsors
lead

Bioheart, Inc.

INDUSTRY

NCT03226093 - Safety Analysis of Implantation of Stromal Vascular Fraction | Biotech Hunter | Biotech Hunter